T. Csont et al., Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of K-ATP, BR J PHARM, 128(7), 1999, pp. 1427-1434
1 We have recently demonstrated that glyceryl trinitrate (GM) exerts a dire
ct myocardial antiischaemic effect in both GTN-tolerant and nontolerant rat
s. Hers we examined if this effect is mediated by GTN-derived nitric oxide
(NO) and involves guanosine 3'5' cyclic monophosphate (cyclic GMP) and ATP-
sensitive K+ channels (K-ATP).
2 Rats were treated with 100 mg kg(-1) GTN or vehicle s.c, three times a da
y for 3 days to induce vascular GTN-tolerance or nontolerance. Isolated wor
king hearts obtained from either GTN-tolerant or nontolerant rats were subj
ected to 10 min coronary occlusion in the presence of 10(-7) M GTN or its s
olvent.
3 GTN improved myocardial function and reduced lactate dehydrogenase (LDH)
release during coronary occlusion in both GTN-tolerant and nontolerant hear
ts.
4 Cardiac NO content significantly increased after GTN administration in bo
th GTN-tolerant and nontolerant hearts as assessed by electron spin resonan
ce. However, cardiac cyclic GMP content measured by radioimmunoassay was no
t changed by GTN administration.
5 When hearts from both GTN-tolerant and nontolerant rats were subjected to
coronary occlusion in the presence of the K-ATP-blocker glibenclamide (10(
-7) M), the drug itself did not affect myocardial function and LDH release,
however, it abolished the anti-ischaemic effect of GTN.
6 We conclude that GTN opens K-ATP via a cyclic GMP-independent mechanism,
thereby leading to an anti-ischaemic effect in the heart in both GTN-tolera
nt and nontolerant rats.